Christopher Bilotto Buys 20,000 Shares of Diversified Healthcare Trust (NASDAQ:DHC) Stock

Diversified Healthcare Trust (NASDAQ:DHC) CEO Christopher Bilotto purchased 20,000 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The stock was acquired at an average price of $4.89 per share, for a total transaction of $97,800.00. Following the completion of the purchase, the chief executive officer owned 266,285 shares of the company’s stock, valued at approximately $1,302,133.65. This represents a 8.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Diversified Healthcare Trust Price Performance

Shares of NASDAQ:DHC traded down $0.09 during trading on Tuesday, hitting $4.82. 717,216 shares of the stock were exchanged, compared to its average volume of 897,762. The company has a fifty day moving average price of $4.47 and a two-hundred day moving average price of $4.00. The company has a market cap of $1.17 billion, a PE ratio of -3.30 and a beta of 2.39. Diversified Healthcare Trust has a 12-month low of $2.00 and a 12-month high of $5.00. The company has a current ratio of 16.89, a quick ratio of 16.89 and a debt-to-equity ratio of 1.61.

Diversified Healthcare Trust (NASDAQ:DHC) last issued its quarterly earnings data on Monday, June 2nd. The real estate investment trust reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $370.78 million during the quarter. Diversified Healthcare Trust had a negative return on equity of 18.90% and a negative net margin of 22.90%.

Diversified Healthcare Trust Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 13th. Shareholders of record on Monday, October 27th were issued a $0.01 dividend. The ex-dividend date was Monday, October 27th. This represents a $0.04 annualized dividend and a yield of 0.8%. Diversified Healthcare Trust’s payout ratio is -2.74%.

Institutional Investors Weigh In On Diversified Healthcare Trust

A number of institutional investors and hedge funds have recently bought and sold shares of DHC. Deutsche Bank AG increased its holdings in shares of Diversified Healthcare Trust by 11.7% in the first quarter. Deutsche Bank AG now owns 233,202 shares of the real estate investment trust’s stock valued at $560,000 after buying an additional 24,510 shares in the last quarter. Nuveen LLC acquired a new position in shares of Diversified Healthcare Trust in the 1st quarter worth $1,673,000. Resona Asset Management Co. Ltd. grew its holdings in shares of Diversified Healthcare Trust by 12.6% in the 1st quarter. Resona Asset Management Co. Ltd. now owns 94,531 shares of the real estate investment trust’s stock worth $233,000 after acquiring an additional 10,562 shares during the last quarter. American Century Companies Inc. acquired a new stake in shares of Diversified Healthcare Trust during the first quarter worth $202,000. Finally, Algert Global LLC lifted its holdings in shares of Diversified Healthcare Trust by 11.3% during the first quarter. Algert Global LLC now owns 390,767 shares of the real estate investment trust’s stock valued at $938,000 after purchasing an additional 39,670 shares during the last quarter. 75.98% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

DHC has been the subject of a number of research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research report on Wednesday, October 8th. Royal Bank Of Canada upgraded shares of Diversified Healthcare Trust from an “underperform” rating to a “sector perform” rating and increased their price objective for the company from $3.00 to $5.00 in a research note on Thursday, November 13th. Finally, B. Riley reiterated a “buy” rating and issued a $6.50 price target (up from $5.50) on shares of Diversified Healthcare Trust in a report on Monday. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $5.75.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.